• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study.

作者信息

Kirklin J K, Naftel D C, Bourge R C, McGiffin D C, Hill J A, Rodeheffer R J, Jaski B E, Hauptman P J, Weston M, White-Williams C

机构信息

University of Alabama at Birmingham, Birmingham, Ala 35293, USA.

出版信息

J Thorac Cardiovasc Surg. 2003 Apr;125(4):881-90. doi: 10.1067/mtc.2003.168.

DOI:10.1067/mtc.2003.168
PMID:12698152
Abstract

BACKGROUND

As therapeutic options evolve for advanced heart failure, the appropriate role for cardiac transplantation will require survival analyses that reflect changing trends in causes of death and patient and institutional risk profiles. Results from multi-institutional studies could be used to monitor progress in individual centers.

METHODS

Between 1990 and 1999, 7290 patients undergoing cardiac transplantation in 42 institutions entered a formal outcomes study. Changing survival, causes of death, and patient risk profiles were analyzed. Multivariable risk-factor equations were applied to a single institution (300 primary heart transplants) to examine differences in risk-adjusted expected versus observed actuarial outcomes over time.

RESULTS

Overall survival in the 42 institutions improved during the decade (P =.02). One- and 3-year cardiac transplant research database survival was as follows: era 1 (1990-1992), 84% and 76%, respectively; era 2 (1993-1995), 85% and 79%, respectively; and era 3 (1996-1999), 85% and 79%, respectively. Causes of death changed over time. Pretransplantation risk profiles increased over time (P =.0001), with increases in reoperations, devices, diabetes, severely ill recipients, pulmonary vascular resistance, sensitization, ischemic times, donor age, and donor inotropic support. Three-year actuarial survival in a single institution was 3% less than risk-adjusted predicted survival in era 1, 1% higher than predicted in era 2, and 7% higher than predicted in era 3.

CONCLUSIONS

Survival after cardiac transplantation is gradually improving, despite increasing risk profiles. Further improvement requires periodic re-evaluation of risk profiles and causes of death to target areas of surveillance, therapy, and research. By using these methods, progress at individual institutions can be assessed in a time-related, risk-adjusted manner that also reflects changing institutional experience, expertise, or both.

摘要

相似文献

1
Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study.
J Thorac Cardiovasc Surg. 2003 Apr;125(4):881-90. doi: 10.1067/mtc.2003.168.
2
Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.心脏移植术后死亡的移植前危险因素:一项多机构研究。移植心脏病学家研究数据库组。
J Heart Lung Transplant. 1993 Jul-Aug;12(4):549-62.
3
Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group.心脏供体与心脏移植受者的匹配。扩大供体库成功的线索:一项多变量、多机构报告。心脏移植研究数据库组
J Heart Lung Transplant. 1994 May-Jun;13(3):353-64; discussion 364-5.
4
Outcome of cardiac transplantation in children. Survival in a contemporary multi-institutional experience. Pediatric Heart Transplant Study.儿童心脏移植的结果。当代多机构经验中的生存率。儿科心脏移植研究。
Circulation. 1996 Nov 1;94(9 Suppl):II69-73.
5
Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients.调整了基线风险因素后,时代对儿科心脏移植受者移植后生存的影响。
J Heart Lung Transplant. 2009 Dec;28(12):1285-91. doi: 10.1016/j.healun.2009.05.003. Epub 2009 Sep 26.
6
Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.1997年至1999年在欧洲移植组织进行的所有连续单纯心脏移植和单纯肺移植的三年生存率。
Clin Transpl. 2003:89-100.
7
Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis.供者特征间的相互作用影响移植后生存:多机构分析。
J Heart Lung Transplant. 2010 Mar;29(3):291-8. doi: 10.1016/j.healun.2009.08.007. Epub 2009 Oct 4.
8
Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. The CASCADE Investigators. Canadian Study of Cardiac Transplant Atherosclerosis Determinants.心脏移植术后早期死亡的预测因素:1981年至1992年加拿大的移植经验。CASCADE研究人员。加拿大心脏移植动脉粥样硬化决定因素研究。
Can J Cardiol. 1998 May;14(5):703-7.
9
Evolving practice patterns in heart transplantation: a single-center experience over 15 years.
Transplant Proc. 2004 Apr;36(3):627-30. doi: 10.1016/j.transproceed.2004.02.052.
10
Impact of pre-operative diabetes mellitus upon early and late survival after heart transplantation: a possible era effect.术前糖尿病对心脏移植术后早期和晚期生存的影响:一种可能的时代效应。
J Heart Lung Transplant. 2005 Sep;24(9):1239-46. doi: 10.1016/j.healun.2004.09.007.

引用本文的文献

1
Incidence of de novo malignancy and all-cause mortality among heart transplant recipients.心脏移植受者新发恶性肿瘤和全因死亡率。
Int J Cardiol. 2024 Nov 15;415:132455. doi: 10.1016/j.ijcard.2024.132455. Epub 2024 Aug 15.
2
Intra-operative Risk Factors Affecting Mortality after Heart Transplantation: A Referral Center Experience in Iran.心脏移植术后死亡率的术中相关危险因素:伊朗转诊中心的经验。
Iran J Med Sci. 2024 Jun 1;49(6):359-368. doi: 10.30476/ijms.2023.99165.3122. eCollection 2024 Jun.
3
Evaluation of 18-FDG PET diagnostic capabilities for cancer screening in heart transplant patients, a retrospective study.
18F-FDG PET 用于心脏移植患者癌症筛查的诊断效能评价:一项回顾性研究。
Medicine (Baltimore). 2023 Sep 29;102(39):e35296. doi: 10.1097/MD.0000000000035296.
4
Beneficial Effects of Tacrolimus on Brain-Death-Associated Right Ventricular Dysfunction in Pigs.他克莫司对猪脑死亡相关右心室功能障碍的有益作用。
Int J Mol Sci. 2023 Jun 21;24(13):10439. doi: 10.3390/ijms241310439.
5
Oral Anticoagulants after Heart Transplantation-Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants.心脏移植术后口服抗凝剂——维生素K拮抗剂与直接口服抗凝剂的比较
J Clin Med. 2023 Jun 28;12(13):4334. doi: 10.3390/jcm12134334.
6
Frequency, Risk Factors, and Clinical Outcomes of Late-Onset Atrial Flutter in Patients after Heart Transplantation.心脏移植术后患者迟发性心房颤动的发生率、危险因素及临床结局
J Cardiovasc Dev Dis. 2022 Oct 3;9(10):337. doi: 10.3390/jcdd9100337.
7
Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death.2010 年至 2020 年间实体器官移植受者死亡原因的趋势:使用 CLASS 方法确定具体死因。
PLoS One. 2022 Jul 25;17(7):e0263210. doi: 10.1371/journal.pone.0263210. eCollection 2022.
8
Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart Transplantation.移植前2型糖尿病与心脏移植后较高的移植物失败率及5年死亡率增加相关。
Front Cardiovasc Med. 2022 Jun 9;9:890359. doi: 10.3389/fcvm.2022.890359. eCollection 2022.
9
Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation.心脏移植术后肺癌患者的危险因素、治疗与预后
Life (Basel). 2021 Dec 4;11(12):1344. doi: 10.3390/life11121344.
10
Resveratrol attenuates stimulated T-cell activation and proliferation: potential therapy against cellular rejection in organ transplantation.白藜芦醇可减轻刺激的T细胞活化和增殖:针对器官移植中细胞排斥反应的潜在疗法。
Am J Clin Exp Immunol. 2020 Dec 15;9(5):81-90. eCollection 2020.